MondayJun 24, 2024 11:15 am

Astiva Health Inc. Dedicated to Serving Growing Number of Older Adults Facing Mental-Health Challenges

Many older adults are at risk of developing mental-health conditions, including depression and anxiety disorders NCOA reports that “fewer than 50% of older adults with mental and/or substance-use disorders receive treatment” Astiva Health is committed to providing strategic, enhanced mental-health services for seniors to help them identify and effectively treat mental-health challenges As baby boomers continue to reach their “golden” years, the number of older adults grappling with mental illness also continues to increase. Astiva Health is committed to providing enhanced mental-health services for its members, as more seniors face mental disorders. “The world’s population is ageing fast,” reports the World Health Organization…

Continue Reading

MondayJun 24, 2024 10:00 am

Commercetools Launches HIPAA-Compliant Innovation to Help Healthcare eCommerce Practitioners

Earlier this week, commercetools rolled out its new HDS-certified, HIPAA-compliant solution, commercetools for Healthcare, which will allow healthcare companies around the world develop and deliver secure, exceptional commerce experiences for their clients at scale. In America, the Health Insurance Portability and Accountability Act (HIPAA) governs the protection of sensitive patient data. Companies that interact with protected health information are required to have various security measures in place to ensure compliance with HIPAA. In some circumstances, this bill also applies to international companies. For instance, when a business that operates outside America works with companies that interact with health information of…

Continue Reading

FridayJun 21, 2024 10:00 am

Brain Cancer in Kids Could Soon Be Detected by 10-Minute Scan

New research carried out by scientists at the University of Birmingham and Newcastle University has determined that a new brain scan could decrease waiting times for diagnosis for children living with brain cancer. The most common form of brain cancer is medulloblastoma, which is further divided into four types: anaplastic or large cell medulloblastoma, medulloblastoma with extensive nodularity, classical medulloblastoma, and nodular or desmoplastic medulloblastoma. Treatment of this cancer differs from one patient to another. In children, this cancer is a common malignant brain tumor that starts developing in the cerebellum. This region in the brain is responsible for coordinating…

Continue Reading

ThursdayJun 20, 2024 12:00 pm

Astiva Health Inc. Solutions Include Growing Number of Activity Centers Focused on Serving Unique Needs of Seniors

Astiva Health Inc. is expanding services, offering healthcare solutions precisely targeted at growing senior demographic “NPJ Aging” reports that U.S. is undergoing a demographic and health transformation that will have profound implications for its healthcare system and society Astiva’s activity centers are designed to be a hub for seniors, providing a space for health education, wellness activities and community building As a record number of people become seniors and enter the season of their lives when quality health care becomes increasingly important, Astiva Health is expanding its services and offering healthcare solutions precisely targeted at this growing demographic. A fast-growing…

Continue Reading

TuesdayJun 18, 2024 12:00 pm

Clene Inc. (NASDAQ: CLNN) CEO and CFO Present Corporate Updates and Future Plans at 72nd Emerging Growth Conference

Clene’s CEO Rob Etherington and CFO Morgan Brown presented highlights and updates on the company’s pipeline – as well as answering questions from the audience Clene has conducted several clinical trials to test the efficacy of CNM-Au8(R), focusing on the diseases amyotrophic lateral sclerosis and multiple sclerosis CNM-Au8 has shown a favorable safety profile, with over 650 collective years of subject exposure without any major safety signals attributed to CNM-Au8 Negotiations are underway to extend the cash runway into 2025, including potential licensing deals and the exercise of warrants that could bring in up to $130 million in additional capital…

Continue Reading

TuesdayJun 18, 2024 11:15 am

HealthLynked Corp. (HLYK) Chairman and CEO, Dr Michael Dent, Shows How His Company’s Pioneering Technology Can Solve Healthcare Problems and Improve Health Outcomes

A recent Bell2Bell interview with HealthLynked Chairman and CEO, Dr. Michael Dent, revealed the company’s technological solution to the common problems in the healthcare industry Florida-based HealthLynked Corp. is dedicated to improving the overall ability of patients and medical providers to partner in improving health outcomes by pioneering a tech platform that improves how medical records are kept and shared HealthLynked also has a rewards program that incentivizes preventive care and helps lower overall costs of healthcare.  It also sells a wide variety of medical supplies at discount HealthLynked recently introduced an AI-powered chatbot to improve patients’ ability to find…

Continue Reading

MondayJun 17, 2024 10:00 am

Robotics Could Revolutionize Medical Diagnostics

Conventional healthcare employs the use of manual testing techniques that are prone to delays and errors. These errors may affect patient care and diagnosis, leading to loss of valuable time for treatment. Robots can be used in different tasks in the healthcare landscape, including analyzing samples and measuring solutions. This allows for results to be released faster and decisions on treatment to be made quicker. The use of robots also reduces errors and increases chances of accurate diagnoses. Additionally, robots prioritize patient safety and care. So, what are some of the other advantages of robots in labs? Decreased contamination risk…

Continue Reading

FridayJun 14, 2024 10:00 am

New Study Stings Medicare Advantage, Calls for Abolition

A recently conducted analysis that examined plans under Medicare Advantage has called for the program, which costs taxpayers in America huge sums, to be abolished. The analysis highlights how, since 2007, the program has fleeced more than $600 billion from the federal government, which offers insurers a lump sum for every patient. In the last 12 months alone, Medicare Advantage plans has surcharged the federal government $82 billion. Currently, these plans are used by over one-half of the eligible population under Medicare. The plans use different strategies to charge higher payments. The paper states that despite these surcharges, Medicare Advantage…

Continue Reading

FridayJun 14, 2024 9:45 am

Astrotech Corp. (NASDAQ: ASTC) Expands Role of Mass Spectrometry in Industrial Processes

In the chemical manufacturing industry, innovative uses of mass spectrometry are a game-changer by ensuring quality control, increased yields, and increased profits Astrotech subsidiary, Pro-Control Inc., has positioned its product line between the need for the chemical manufacturers to offset lower prices with efficiency gains that could offset potential losses The Pro-Control Maximum Value Processing(TM) can perform in-situ process tests every 5 minutes greatly increasing efficiency across a wide range of chemical manufacturing processes Mass spectrometry (“MS”) is becoming a transformative analytical technique that has revolutionized how materials are tested and processed in various industries, such as petrochemical. The supreme…

Continue Reading

FridayJun 14, 2024 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases

INM is advancing INM-089 targeting age-related macular degeneration and INM-901 targeting Alzheimer’s disease The company recently posted positive results for INM-089 demonstrating significant functional and pathological improvements in an AMD disease model Recent preclinical data for INM-901 displayed positive pharmacological effects for treating Alzheimer's disease INM posted a business update for Q3-2024 reporting a closing cash position of US$7.9 million and revenue growth for subsidiary BayMedica, a supplier of rare cannabinoids as ingredients InMed Pharmaceuticals (NASDAQ: INM), a is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050